Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Ongoing Initiated Aug 6, 2026 (2 months ago)

Acthar Gel (Repository Corticotropin)

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Presence of particulate matter: glass and stopper piece

Cause type: Particulate / foreign matter

Visible foreign particles - glass, metal, fibers or other material - found in the product. Particles can enter from equipment wear, containers or the process, and are dangerous in injectables. All particulate / foreign matter recalls.

What was recalled

Acthar Gel (repository corticotropin injection), 5 mL multiple-dose vial, Rx Only, Mfd. for: Mallinckrodt ARD LLC, Bridgewater, NJ 08807, NDC 63004-8710-1 & NDC 63004-8710-2

Affected NDCs 63004-8710-01 63004-8710-02

Compare with the code on your package — it is the most precise check available.

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
Acthar
Repository Corticotropin
NDC 63004-8710
CORTICOTROPIN 80 [USP'U]/mL Injection
Intramuscular|subcutaneous
Mallinckrodt ARD LLC Rx
Recalling firm
Mallinckrodt Hospital Products Inc.
NDC code
63004-8710-1
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0803-2026 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall.

Other recalls by Mallinckrodt Hospital Products Inc.

All 2026 recalls
Class II · Moderate risk

Terlivaz (terlipressin for injection)

cGMP deviations: Temperature excursion due to shipping delay from manufacturer to distributor. Affected distributor has been notified.

Ongoing Temperature excursion Mallinckrodt Hospital Products Inc. NDC 43825-200-01 D-0341-2024
Class II · Moderate risk

Acthar Gel

cGMP deviations: Temperature excursion due to shipping delay from manufacturer to distributor. Affected distributor has been notified.

Ongoing Temperature excursion Mallinckrodt Hospital Products Inc. NDC 63004-8710-1 D-0340-2024

Other particulate / foreign matter recalls from 2026

All particulate / foreign matter recalls
Class I · High risk

Dextrose Injection

Presence of Particulate Matter: particulate matter identified as stainless steel particles in the solution.

Ongoing Particulate / foreign matter Baxter Healthcare Corporation NDC 00338-0719-06 D-0850-2026